China's telemedicine market size is at around $4.88 Bn in 2022 and is projected to reach $20.6 Bn in 2030, exhibiting a CAGR of 19.7% during the forecast period 2022-2030. China's Telemedicine Market is segmented by component, modality, delivery mode, and facility. Changes in healthcare insurance coverage and restrictions have a substantial impact on people's out-of-pocket expenses, which fuels the Chinese telemedicine market's demand. Some of the top players are Ping An Healthcare & Technology Co., Alibaba Health Information Technology Ltd., JD Health International Inc., and Medix.
China's telemedicine market size is at around $4.88 Bn in 2022 and is projected to reach $20.6 Bn in 2030, exhibiting a CAGR of 19.7% during the forecast period. The percentage of GDP devoted to healthcare in China in 2021 was down from 7.1% the year before to approximately 6.7%. In terms of relative numbers, health spending as a percentage of GDP has been rising over the past 20 years and has recently surpassed 6%. The National Health Commission reports that there are currently 6.7 medical beds per 1,000 people in China, and there are less than 4 intensive care units (ICU) per 100,000 people, indicating a serious disparity between the number of patients and available medical resources.
The COVID-19 situation at the start of 2020 explains why the 2% increase in the penetration rate of telemedicine year over year was expected. By April 2019, there were 45 Mn active users of online telemedicine services in China, with a 6.6% market penetration rate. The potential demand for telemedicine in the central and western regions is enormous because more than 70% of third-level grade-A hospitals are situated in the eastern region.
Market Growth Drivers Analysis
In China, telemedicine began relatively late, but with the help of 5G technology and the COVID-19 scenario, its applications have grown to include remote ultrasound, remote surgery, and even remote first aid. According to the National Health Commission, China now has less than 4 intensive care units (ICU) per 100,000 people and only 6.7 hospital beds per 1,000 people, indicating a significant imbalance between the number of patients and the available medical resources. This factor plays an important factor in the growth of the telemedicine market in the country. In China, the market for online healthcare was dominated in 2021 by online pharmacies and digital healthcare infrastructure.
Changes in healthcare insurance coverage and rules have a significant impact on individuals' out-of-pocket expenses. This could result in differences in services and have an effect on the standard of care.
Patients frequently have to pay out of cash due to differences in coverage between and between federal and private payers. Before co-insurance kicks in, patients can be responsible for a co-pay, co-insurance, facility fees, and reaching a large deductible. As the majority of these services are not covered by health insurance, this may discourage people from choosing telemedicine services.
December 2022: To provide 24-hour medical consultations, JD Health launched its "online anti-COVID clinic." The telemedicine service is anticipated to offer people the much-needed support they need to cope with the rise in infections, with an average response time of less than 30 seconds.
January 2022: The digital healthcare company, ETAO International Group, will be valued at $2.5 Bn after merging with a blank-check business and going public. Healthcare services from ETAO, including hospital and primary care, health insurance, pharmacies, and telemedicine, are offered both online and offline in China.
The three main enforcement priorities in relation to digital health are personal information protection, data security, and cybersecurity. China has established the Personal Information Protection Law, the Data Security Law, and the Cybersecurity Law, all of which went into effect on November 1, 2021. The Multi-Level Protection Scheme ("MLPs") implemented in the field of cybersecurity has become a main focus in enforcement in most industries, including digital health. MLPs are an obligatory legal requirement stipulated by the Cybersecurity Law and pertinent regulations. The National Health Commission – Internet-based diagnosis and treatment and remote consultations between healthcare institutions are regulated by the NHC. The National Medical Products Administration ("NMPA”): The NMPA regulates drugs, medical devices, and cosmetics, and is responsible for the safety, supervision, and management of standard formulation, registration, manufacturing, and post-market risk management.
Basic Medical Insurance (BMI) serves as the foundation and medical aid serves as the backup for China's multilevel national medical security system. Commercial health insurance, charitable contributions, and medical mutual aid activities serve as supplemental services. The cost of telemedicine services is currently not covered by the state's medical insurance, but it is anticipated that in the future these costs will be covered by the state's medical insurance. Since it is challenging to determine and standardize the prices of different telemedicine services offered throughout the nation and since the majority of these services are not covered by health insurance, this may discourage people from choosing telemedicine services.
1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
18.104.22.168 Product Applications and Services
22.214.171.124 Recent Developments
126.96.36.199 Partnerships Ecosystem
188.8.131.52 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
The industry is driven by three concepts, which include real-time (synchronous), store and forward (asynchronous), and others comprising remote patient monitoring, etc.
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses